Core Scientific, Inc.
CORZ
$22.79
-$0.16-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 126.45% | 58.87% | |||
| Total Other Revenue | -28.60% | -26.59% | |||
| Total Revenue | 44.48% | -1.65% | |||
| Cost of Revenue | 101.19% | -45.18% | |||
| Gross Profit | -19.60% | 858.90% | |||
| SG&A Expenses | 17.70% | -39.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -89.37% | 662.83% | |||
| Total Operating Expenses | -3.86% | 9.44% | |||
| Operating Income | 65.45% | -27.81% | |||
| Income Before Tax | -261.77% | 246.21% | |||
| Income Tax Expenses | 531.58% | -24.00% | |||
| Earnings from Continuing Operations | -262.12% | 246.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -262.12% | 246.02% | |||
| EBIT | 65.45% | -27.81% | |||
| EBITDA | 89.73% | -48.55% | |||
| EPS Basic | -279.59% | 227.54% | |||
| Normalized Basic EPS | -121.27% | 316.03% | |||
| EPS Diluted | -360.76% | 187.84% | |||
| Normalized Diluted EPS | -130.92% | 248.59% | |||
| Average Basic Shares Outstanding | 1.04% | 0.33% | |||
| Average Diluted Shares Outstanding | -30.49% | 45.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||